The MAPK/ERK signaling pathway is one more vital target for inhibitors. Inhibitors targeting MAPK/ERK are used in cancer treatments to protect against unchecked cell spreading and lump development.Antibiotics are a subset of inhibitors that have changed the monitoring of bacterial infections. By targeting bacterial cell walls, protein synthesis, or… Read More